Private company

Thrombolytic Science International

Logo: Thrombolytic Science International, Non-free logo, via Wikipedia3

American biotechnology company based in Cambridge1

Thrombolytic Science, LLC (TSI) is a private, clinical stage biopharmaceutical company that was founded in 2006 based on the research of Harvard scientist Victor Gurewich into the potential use of prourokinase to break up blood clots. Gurewich co-founded the company and the founding CEO is business person Alexis Wallace.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

  • Industrybiotechnology1
  • HeadquartersCambridge1
  • Websitetsillc.net

Thrombolytic Science, LLC (TSI) is a private, clinical stage biopharmaceutical company that was founded in 2006 based on the research of Harvard scientist Victor Gurewich into the potential use of prourokinase to break up blood clots. Gurewich co-founded the company and the founding CEO is business person Alexis Wallace.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3